Logo image of 1MEDP.MI

MEDPACE HOLDINGS INC (1MEDP.MI) Stock Analyst Earnings Estimates

BIT:1MEDP - Euronext Milan - US58506Q1094 - Common Stock - Currency: EUR

387.7  +387.7 (+Infinity%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
1MEDP.MI revenue by date.1MEDP.MI revenue by date.
1.46B
27.80%
1.886B
29.17%
2.109B
11.84%
2.229B
5.69%
2.304B
3.36%
2.499B
8.46%
2.71B
8.44%
2.949B
8.82%
3.107B
5.36%
3.392B
9.17%
3.707B
9.29%
EBITDA
YoY % growth
1MEDP.MI ebitda by date.1MEDP.MI ebitda by date.
301.1M
37.05%
363.153M
20.61%
476.121M
31.11%
484.58M
1.78%
506.38M
4.50%
555.23M
9.65%
614.65M
10.70%
687.68M
11.88%
753.28M
9.54%
839.55M
11.45%
936.06M
11.50%
EBIT
YoY % growth
1MEDP.MI ebit by date.1MEDP.MI ebit by date.
278.7M
40.33%
336.825M
20.86%
446.87M
32.67%
454.78M
1.77%
471.67M
3.71%
518.94M
10.02%
582.01M
12.15%
653.34M
12.26%
713.84M
9.26%
797.41M
11.71%
891.06M
11.74%
Operating Margin
1MEDP.MI operating margin by date.1MEDP.MI operating margin by date.
19.09%17.86%21.19%20.40%20.47%20.77%21.48%22.15%22.98%23.51%24.04%
EPS
YoY % growth
1MEDP.MI eps by date.1MEDP.MI eps by date.
7.32
52.18%
8.88
21.31%
12.63
42.23%
13.00
2.91%
13.43
3.30%
14.86
10.65%
16.68
12.26%
18.82
12.87%
20.94
11.24%
23.36
11.57%
26.08
11.64%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
3.44
14.27%
3.66
-0.17%
3.18
-13.27%
3.44
10.82%
3.56
3.44%
3.81
3.95%
3.97
24.76%
4.15
20.74%
4.29
20.70%
4.55
19.44%
Revenue
Q2Q % growth
621.35M
16.51%
635.91M
18.51%
560.12M
0.28%
596.07M
-1.20%
619.15M
-0.35%
640.91M
0.79%
652.84M
16.55%
673.8M
13.04%
698.34M
12.79%
725.14M
13.14%
EBITDA
Q2Q % growth
131.54M
-1.85%
138.07M
-10.71%
121.12M
0.55%
129.86M
-7.43%
133.68M
1.63%
142.14M
2.95%
150.9M
24.59%
155.86M
20.02%
159.99M
19.68%
167M
17.49%
EBIT
Q2Q % growth
123.92M
10.37%
129.69M
3.44%
113.16M
-0.32%
121.75M
-3.63%
126.22M
1.86%
136.14M
4.97%
143.01M
26.38%
147.91M
21.49%
151.87M
20.32%
158.74M
16.60%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
3.10
12.73%
3.020.082.57%
Q1 2025
Q2Q % growth
3.67
14.69%
3.110.5617.84%
Q4 2024
Q2Q % growth
3.67
49.19%
3.020.6521.62%
Q3 2024
Q2Q % growth
3.01
35.59%
2.830.186.19%
Q2 2024
Q2Q % growth
2.75
42.49%
2.590.166.29%
Q1 2024
Q2Q % growth
3.20
40.97%
2.510.6927.27%
Q4 2023
Q2Q % growth
2.46
16.04%
2.270.198.54%
Q3 2023
Q2Q % growth
2.22
8.29%
2.090.136.38%
Q2 2023
Q2Q % growth
1.93
32.19%
1.95-0.02-1.18%
Q1 2023
Q2Q % growth
2.27
34.32%
1.840.4323.57%
Q4 2022
Q2Q % growth
2.12
60.61%
1.820.3016.37%
Q3 2022
Q2Q % growth
2.05
58.91%
1.500.5536.37%
Q2 2022
Q2Q % growth
1.46
37.74%
1.340.129.10%
Q1 2022
Q2Q % growth
1.69
48.25%
1.290.4031.39%
Q4 2021
Q2Q % growth
1.32
-2.22%
1.280.043.45%
Q3 2021
Q2Q % growth
1.29
18.35%
1.100.1917.78%
Q2 2021
Q2Q % growth
1.06
55.88%
1.010.055.01%
Q1 2021
Q2Q % growth
1.14
42.50%
1.020.1211.36%
Q4 2020
Q2Q % growth
1.35
58.82%
1.270.086.66%
Q3 2020
Q2Q % growth
1.09
53.52%
1.10-0.01-0.48%
Q2 2020
Q2Q % growth
0.68
-16.05%
0.420.2661.20%
Q1 2020
Q2Q % growth
0.80
25.00%
0.760.044.92%
Q4 2019
Q2Q % growth
0.85 0.770.0810.57%
Q3 2019
Q2Q % growth
0.71 0.73-0.02-2.35%
Q2 2019
Q2Q % growth
0.81 0.650.1625.02%
Q1 2019
Q2Q % growth
0.64 0.610.034.48%
1MEDP.MI Yearly EPS VS Estimates1MEDP.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5 10 15 20 25
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
603.311M
14.24%
549.55M53.761M9.78%
Q1 2025
Q2Q % growth
558.57M
9.30%
536.87M21.7M4.04%
Q4 2024
Q2Q % growth
536.589M
7.66%
545.48M-8.891M-1.63%
Q3 2024
Q2Q % growth
533.317M
8.29%
551.81M-18.493M-3.35%
Q2 2024
Q2Q % growth
528.104M
14.58%
539.19M-11.086M-2.06%
Q1 2024
Q2Q % growth
511.044M
17.72%
522.84M-11.796M-2.26%
Q4 2023
Q2Q % growth
498.401M
26.47%
508.69M-10.289M-2.02%
Q3 2023
Q2Q % growth
492.5M
28.36%
485.27M7.23M1.49%
Q2 2023
Q2Q % growth
460.9M
31.24%
442.37M18.53M4.19%
Q1 2023
Q2Q % growth
434.1M
31.19%
409.84M24.26M5.92%
Q4 2022
Q2Q % growth
394.1M
27.71%
393.73M370K0.09%
Q3 2022
Q2Q % growth
383.7M
29.80%
364.33M19.37M5.32%
Q2 2022
Q2Q % growth
351.2M
26.19%
350.9M300K0.09%
Q1 2022
Q2Q % growth
330.9M
27.27%
333.64M-2.74M-0.82%
Q4 2021
Q2Q % growth
308.6M
18.83%
315.22M-6.62M-2.10%
Q3 2021
Q2Q % growth
295.6M
28.30%
297.39M-1.79M-0.60%
Q2 2021
Q2Q % growth
278.3M
35.76%
277.54M760K0.27%
Q1 2021
Q2Q % growth
260M
12.60%
270.59M-10.59M-3.91%
Q4 2020
Q2Q % growth
259.7M
12.96%
250.88M8.82M3.52%
Q3 2020
Q2Q % growth
230.4M
6.57%
228.03M2.37M1.04%
Q2 2020
Q2Q % growth
205M
-4.25%
184.14M20.86M11.33%
Q1 2020
Q2Q % growth
230.9M
15.05%
230.5M400K0.17%
Q4 2019
Q2Q % growth
229.9M 226.17M3.73M1.65%
Q3 2019
Q2Q % growth
216.2M 221.48M-5.28M-2.38%
Q2 2019
Q2Q % growth
214.1M 205M9.1M4.44%
Q1 2019
Q2Q % growth
200.7M 194.14M6.56M3.38%
1MEDP.MI Yearly Revenue VS Estimates1MEDP.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A